Page 26 - Summer 2017 Journal

chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis 31.
D, cholesterol-containing diet. Atherosclerosis 1972;16(1):105-18.
3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis
of arteriosclerosis. Am J Pathol 1969;56(1):111-28.
4. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, et al. Hydrogen 32.
sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 2007;104(46):17977-82.
5. Szczesny B, Módis K, Yanagi K, Coletta C, Le Trionnaire S, Perry A, et al. AP39, a novel
mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts 33. cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide 2014;41:120-30. 34.
6. Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. QJM 1996;89(8):579-89.
7. MacPherson A, Bacsó J. Relationship of hair calcium concentration to incidence of coronary 35. heart disease. Sci Total Environ 2000;255(1-3):11-19.
8. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11. 36.
9. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012;97(10):3557-68. 37.
10. Seneff S, Lauritzen A, Davidson R, Lentz-Marino L. Is endothelial nitric oxide synthase a moonlighting protein whose day job is cholesterol sulfate synthesis? Implications for cholesterol transport, diabetes and cardiovascular disease. Entropy 2012;14(12):2492-2530.
11. Tian Q-Y, Sun D-H, Zhao M-G, Zhang W-H. Inhibition of nitric oxide synthase (NOS) 38. underlies aluminum-induced inhibition of root elongation in Hibiscus moscheutos. New Phytol 2007;174(2):322-31.
12. Alexidis AN, Rekka EA, Kourounakis PN. Influence of mercury and cadmium intoxication
on hepatic microsomal CYP2E and CYP3A subfamilies. Res Commun Mol Pathol Pharmacol 39. 1994;85(1):67-72.
13. Korashy HM, El-Kadi AOS. Modulation of TCDD-mediated induction of cytochrome
P450 1A1 by mercury, lead and copper in human HepG2 cell line. Toxicology in Vitro 2008;22(1):154-8. 40.
14. Anwar-Mohamed A, El-Sherbeni AA, Kim SH, Althurwi HN, Zordoky BN, El-Kadi AO.
Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associ- 41. ated arachidonic acid metabolism in C57Bl/6 mouse heart. Xenobiotica 2012;42(12):1235-47.
Emdin M, Pompella A, Paolicchi A. Gamma-glutamyl- transferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112(14):2078-80.
Mao Y, Qi X, Xu W, Song H, Xu M, Ma W, et al. Serum gamma-glutamyl transferase: a novel biomarker for coro- nary artery disease. Med Sci Monit 2014;20:706-10. Joseph CA, Maroney MJ. Cysteine dioxygenase: structure and mechanism. Chem Commun 2007;32:3338-49.
Shi Y, Tokunaga O. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int 2002;52(12):755-63.
Tufano A, Di Capua M, Coppola A, Conca P, Cimino E, Cerbone AM, et al. The infectious burden in atherothrom- bosis. Semin Thromb Hemost 2012;38(5):515-23. Neumann FJ. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. Circula- tion 2002;106(19):2414-6.
Rasmussen-Lathrop SJ, Koshiyama K, Phillips N, Stephens RS. Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell Microbiol 2000;2(2):137-44.
Smolina K, Wright FL, Rayner M, Goldacre MJ. Deter- minants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
Allender S, Scarborough P, O’Flaherty M, Capewell S. Patterns of coronary heart disease mortality over the 20th century in England and Wales: possible plateaus in the rate of decline. BMC Public Health 2008;8:148.
Roger VL. The heart failure epidemic. Int J Environ Res Public Health 2010;7(4):1807-30.
Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
15. Samsel A, Seneff S. Glyphosate’s suppression of cytochrome P450 enzymes and amino acid
biosynthesis by the gut microbiome: pathways to modern diseases. Entropy 2013;15(4):1416- 42.
1463. autoantibodies are specifically increased in chronic cha-
16. Samsel A, Seneff S. Glyphosate, pathways to modern diseases II: celiac sprue and gluten intolerance. Interdiscip Toxicol 2013;6(4):159-84. 43.
17. Verhaar MC, Westerweel PE, van Zonneveld AJ, Rabelink TJ. Free radical production by dysfunctional eNOS. Heart 2004;90(5):494-495.
18. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, et al. Red blood cells express 44. a functional endothelial nitric oxide synthase. Blood 2006;107(7):2943-51.
19. Hietanen E, Linnainmaa K, Vainio H. Effects of phenoxyherbicides and glyphosate on
the hepatic and intestinal biotransformation activities in the rat. Acta Pharmacol Toxicol 45. (Copenh) 1983;53(2):103-12.
20. Lorbek G, Lewinska M, Rozman D. Cytochrome P450s in the synthesis of cholesterol and bile acids – from mouse models to human diseases. FEBS J 2012;279(9):1516-33.
21. Erickson SK, Lear SR, Deane S, Dubrac S, Huling SL, Nguyen L, et al. Hypercholesterol-
emia and changes in lipid and bile acid metabolism in male and female CYP7A1-deficient 46. mice. J Lipid Res 2003;44:1001-9.
22. Davidson RM, Seneff S. The initial common pathway of inflammation, disease, and sudden 47. death. Entropy 2012;14(8):1399-1442.
23. Tumova S, Woods A, Couchman JR. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 2000;32(3):269-88. 48.
24. MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, Witztum JL, et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins indepen- dently of LDL receptor family members. J Clin Invest 2007;117(1):153-64. 49.
25. Collins KD. Charge density-dependent strength of hydration and biological structure. Biophys J 1997;72(1):65-76.
26. Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation 1986;74(5):1071-4. 50.
27. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004;286(5):H1672-H1680.
28. Yanai H, Javitt NB, Higashi Y, Fuda H, Strott CA. Expression of cholesterol sulfotransferase (SULT2B1b) in human platelets. Circulation 2004;109(1):92-6. 51.
29. Paka L, Kako Y, Obunike JC, Pillarisetti S. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active 52. heparin-like domains: a potential mechanism for the anti-atherogenic actions of vascular apolipoprotein E. J Biol Chem 1999;274:4816-23.
30. McCully KS. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 2009;39(3):219-32. 53.
26
gasic human patients. Clin Exp Immunol 1996;103(1):40-6. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas’ disease: a clinical, epidemiologic, and pathologic study. Circulation 1956;14:1035-60.
Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG. Down’s syndrome: an atheroma-free model? Br Med J 1977;2(6081):226-8.
Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, et al. Transgenic mice with increased Cu/ Zn-superoxide dismutase activity: animal model of dos- age effects in Down syndrome. Proc Natl Acad Sci USA 1987;84(22):8044-8.
Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health 2007;17(2):221-5. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46(8):849- 53.
Brooksbank BWL, Balazs R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down’s syndrome fetal brain. Brain Res 1984;318(1):37-44. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 1985;17(3);278- 82.
Han X, Holtzman DM, McKeel DW Jr, Kelley J, Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J Neurochem 2002;82(4):809-18. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004;109(23 Suppl 1):III39-III43. Jasińska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and con- sequent pleiotropic effects. Pharmacol Rep 2007;59(5): 483-99.
Weitz-Schmidt G. Statins as anti-inflammatory agents.
Avila JL, Rojas M, Avila A. Cholesterol sulphate-reactive
Wise Traditions
SUMMER 2017